Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 234Squamous Cell Carcinoma of Head and Neck 168Head and Neck Neoplasms 141Lung Neoplasms 110Esophageal Neoplasms 109Nasopharyngeal Carcinoma 104Uterine Cervical Neoplasms 101Stomach Neoplasms 88Esophageal Squamous Cell Carcinoma 86Breast Neoplasms 69Urinary Bladder Neoplasms 66Small Cell Lung Carcinoma 58Pancreatic Neoplasms 56Neoplasms 55Carcinoma, Squamous Cell 55Cholangiocarcinoma 52Ovarian Neoplasms 45Neoplasm Metastasis 44Oropharyngeal Neoplasms 43Biliary Tract Neoplasms 41Adenocarcinoma Of Esophagus 35Recurrence 29Mesothelioma, Malignant 28Triple Negative Breast Neoplasms 25Laryngeal Neoplasms 25Nasopharyngeal Neoplasms 24Lymphoma 24Gallbladder Neoplasms 24Sarcoma 21Carcinoma 21

Interventions

rofecoxib 1rindopepimut 1ovex 1Thalidomide 1Re-Irradiation 1Piperazine 1Mebendazole 1Irinotecan 1Everolimus 1Dasatinib 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Brain Stem Neoplasms × Cisplatin × Clear all
NCT01574092 2015-08-24

Irinotecan in Combination With Cisplatin in Pediatric Patients With Unfavorable Prognosis Gliomas

Hospital Sant Joan de Deu

Phase 2 Completed
39 enrolled
CNS

Brain Neoplasms, Glioma, Brain Stem Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡